[Molecular characteristics of serogroup B neisseria meningitidis, China]. 2019

B Q Zhu, and W Y Gao, and L Xu, and Y Gao, and Z J Shao
State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.

Objective: To investigate the molecular characteristics of serogroup B neisseria meningitidis in China. Methods: Total of 485 (100 strains isolated from cerebrospinal fluid or blood samples of encephalomyelitis cases, and 385 strains isolated from nasopharynx of healthy carriers) Meningococcal serogroup B (MenB) strains, isolated from 29 provinces of China between 1968 and 2016, were analyzed by multilocus sequence typing (MLST) and PorA typing methods. Further, the genetic diversity of three MenB vaccine proteins, FHbp, NadA and NHBA, were analyzed. Results: The 485 study strains belonged to 270 sequence types (STs), 107 of which (representing 211 strains) could be grouped into ten clonal complexes (CC). CC4821 has been the predominant lineage in China since 2005 (28.7%, n=139). The most common PorA types of MenB strains from invasive meningococcal cases were P1.5-2,2-2 (10.0%, n=10), P1.5-1,2-2 (9.0%, n=9) and P1.5-1,10-4 (9.0%, n=9). Four hundred and twenty one strains had intact fhbp gene; variant 1, 2 and 3 accounted for 12.8% (54 strains), 85.0% (358 strains) and 2.2% (9 strains) respevtively. Ten out of 432 strains (2.3%) contained complete nadA gene. All the 172 strains for which the nhba gene was sequenced had intact gene sequence which corresponded to 68 peptide types. Conclusion: CC4821 was the predominant CC of MenB strains in China; the vaccine proteins were diverse about the sequences. The vaccine proteins should be carefully selected when developing MenB vaccines in China.

UI MeSH Term Description Entries
D008589 Meningococcal Infections Infections with bacteria of the species NEISSERIA MENINGITIDIS. Meningococcal Septicemia,Infections, Meningococcal,Meningococcal Disease,Infection, Meningococcal,Meningococcal Diseases,Meningococcal Infection,Septicemia, Meningococcal
D002681 China A country spanning from central Asia to the Pacific Ocean. Inner Mongolia,Manchuria,People's Republic of China,Sinkiang,Mainland China
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000942 Antigens, Bacterial Substances elaborated by bacteria that have antigenic activity. Bacterial Antigen,Bacterial Antigens,Antigen, Bacterial
D058885 Multilocus Sequence Typing Direct nucleotide sequencing of gene fragments from multiple housekeeping genes for the purpose of phylogenetic analysis, organism identification, and typing of species, strain, serovar, or other distinguishable phylogenetic level. Multilocus Sequence Analysis,Analyses, Multilocus Sequence,Analysis, Multilocus Sequence,Multilocus Sequence Analyses,Sequence Analyses, Multilocus,Sequence Analysis, Multilocus,Sequence Typing, Multilocus,Typing, Multilocus Sequence
D022401 Meningococcal Vaccines Vaccines or candidate vaccines used to prevent infection with NEISSERIA MENINGITIDIS. Bivalent Meningococcal Vaccine,Menactra,Meningococcal Polysaccharide Vaccine,Meningococcal Vaccine,Menomune,Menveo,Tetravalent Meningococcal Vaccine,Meningococcal Vaccine, Bivalent,Meningococcal Vaccine, Tetravalent,Polysaccharide Vaccine, Meningococcal,Vaccine, Meningococcal,Vaccine, Meningococcal Polysaccharide,Vaccines, Meningococcal
D038541 Neisseria meningitidis, Serogroup B Strains of Neisseria meningitidis which are the most common ones causing infections or disease in infants. Serogroup B strains are isolated most frequently in sporadic cases, and are less common in outbreaks and epidemics. Meningococcus, Serogroup B,Meningococci, Serogroup B

Related Publications

B Q Zhu, and W Y Gao, and L Xu, and Y Gao, and Z J Shao
January 2001, International reviews of immunology,
B Q Zhu, and W Y Gao, and L Xu, and Y Gao, and Z J Shao
February 2010, Emerging infectious diseases,
B Q Zhu, and W Y Gao, and L Xu, and Y Gao, and Z J Shao
January 2012, PloS one,
B Q Zhu, and W Y Gao, and L Xu, and Y Gao, and Z J Shao
September 2007, Journal of medical microbiology,
B Q Zhu, and W Y Gao, and L Xu, and Y Gao, and Z J Shao
April 2013, Microbial pathogenesis,
B Q Zhu, and W Y Gao, and L Xu, and Y Gao, and Z J Shao
March 2011, Emerging infectious diseases,
B Q Zhu, and W Y Gao, and L Xu, and Y Gao, and Z J Shao
March 2008, The Journal of infection,
B Q Zhu, and W Y Gao, and L Xu, and Y Gao, and Z J Shao
December 2019, The Journal of infection,
B Q Zhu, and W Y Gao, and L Xu, and Y Gao, and Z J Shao
June 1996, Journal of clinical microbiology,
B Q Zhu, and W Y Gao, and L Xu, and Y Gao, and Z J Shao
October 1998, Journal of clinical microbiology,
Copied contents to your clipboard!